10.4 Multiple Gestation, Fetal Growth Disorders, Amniotic Fluid Abnormalities, Malpresentation & Postterm Pregnancy

Key Takeaways

  • Monochorionic twins need ultrasound every 2 weeks from 16 weeks to detect twin-twin transfusion syndrome; ACOG delivery timing is 38 0/7–38 6/7 weeks for dichorionic and 34 0/7–37 6/7 weeks for monochorionic-diamniotic twins.

  • SMFM defines fetal growth restriction as an estimated fetal weight or abdominal circumference below the 10th percentile; umbilical artery Doppler findings guide surveillance and delivery timing.

  • ACOG suggests offering cesarean birth for suspected macrosomia when the estimated fetal weight is at least 5,000 g without diabetes or at least 4,500 g with diabetes.

  • External cephalic version is offered at 37 0/7 weeks or later for breech presentation when there are no contraindications, and Rh(D)-negative patients receive anti-D immune globulin.

  • Late-term pregnancy begins at 41 0/7 weeks and postterm at 42 0/7 weeks; antenatal testing starts at 41 weeks, induction can be considered from 41 0/7 weeks, and ACOG recommends induction after 42 0/7 and by 42 6/7 weeks.

Last updated: October 2026

Multiple Gestation

Twins occur in about 3% of U.S. births, more often with assisted reproduction and older maternal age.

  • Maternal risks: Preeclampsia (aspirin is indicated), gestational diabetes, anemia, hyperemesis, preterm birth (about 60% of twins deliver before 37 weeks), and postpartum hemorrhage.
  • Fetal risks: Preterm birth, growth restriction, growth discordance (20% or more), anomalies, and stillbirth; monochorionic twins add twin-twin transfusion syndrome (TTTS), which occurs in about 10%–15% of monochorionic-diamniotic pairs, and monoamniotic twins add cord entanglement.
  • Care: Determine chorionicity in the first trimester. Ultrasound every 4 weeks or so for dichorionic twins; every 2 weeks from 16 weeks for monochorionic twins to watch for TTTS (polyhydramnios in the recipient and oligohydramnios in the donor). Weight gain goal for a normal-BMI twin pregnancy is about 37–54 lb.
Twin TypeACOG Delivery Timing (uncomplicated)
Dichorionic-diamniotic38 0/7–38 6/7 weeks
Monochorionic-diamniotic34 0/7–37 6/7 weeks
Monochorionic-monoamniotic32 0/7–34 0/7 weeks (usually by cesarean)

Vaginal birth is reasonable when the first twin is cephalic; cesarean is usual when the first twin is not cephalic.


Fetal Growth Restriction (FGR)

  • Definition (SMFM 2020): Estimated fetal weight (EFW) or abdominal circumference below the 10th percentile; severe FGR is below the 3rd percentile. Small for gestational age (SGA) describes a newborn whose birth weight is below the 10th percentile.
  • Causes: Maternal (hypertension, preeclampsia, diabetes with vascular disease, smoking, substance use, malnutrition, autoimmune disease), placental (abnormal spiral artery remodeling, abruption, cord abnormalities), and fetal (aneuploidy, structural anomalies, infection such as CMV).
  • Evaluation: Detailed anatomy survey; genetic counseling and diagnostic testing for early-onset FGR (before 32 weeks) or FGR with anomalies or polyhydramnios; CMV testing.
  • Surveillance: Umbilical artery Doppler is the key test; add amniotic fluid assessment and NST or biophysical profile.
Doppler FindingTypical Delivery Timing (SMFM)
EFW 3rd–10th percentile, normal Doppler38 0/7–39 0/7 weeks
EFW below the 3rd percentile or decreased diastolic flow37 0/7 weeks
Absent end-diastolic velocity33 0/7–34 0/7 weeks
Reversed end-diastolic velocity30 0/7–32 0/7 weeks

Give antenatal corticosteroids when delivery before 34 weeks is likely, and magnesium for neuroprotection before 32 weeks.

Macrosomia and Large for Gestational Age

  • Definitions: Birth weight of 4,000 g or 4,500 g or more (macrosomia); large for gestational age is above the 90th percentile.
  • Risk factors: Diabetes (pregestational or gestational), obesity, excessive weight gain, prior macrosomic infant, and postterm pregnancy.
  • Limitations: Ultrasound and clinical estimates of fetal weight are imprecise.
  • ACOG Practice Bulletin 216: Suspected macrosomia alone is not an indication for induction before 39 weeks. Offer scheduled cesarean when EFW is at least 5,000 g without diabetes or at least 4,500 g with diabetes to reduce shoulder dystocia and brachial plexus injury.

Amniotic Fluid Abnormalities

FindingDefinitionCommon CausesManagement
OligohydramniosDeepest vertical pocket <2 cm (preferred) or AFI ≤5 cmPPROM, placental insufficiency (FGR), renal agenesis or obstruction, postterm pregnancy, NSAIDs or ACE inhibitorsRule out rupture of membranes and FGR; hydrate; increased surveillance; isolated oligohydramnios at term is delivered at 36 0/7–37 6/7 weeks
PolyhydramniosDeepest vertical pocket ≥8 cm or AFI ≥24 cmMaternal diabetes, fetal swallowing defects (esophageal or duodenal atresia, neuromuscular disorders), fetal anemia or hydrops, twins with TTTS, idiopathicDiabetes screening, detailed anatomy scan, antibody screen, infection testing; risks include preterm labor, malpresentation, cord prolapse at rupture, and postpartum hemorrhage

Malpresentation

  • Breech presentation affects about 3%–4% of term pregnancies (frank, complete, or footling).
  • External cephalic version (ECV): Offer at 37 0/7 weeks or later (when spontaneous version is unlikely but an emergency term delivery is acceptable). Success is about 50%–60%, higher in multiparous patients. Contraindications include placenta previa, a nonreassuring fetal tracing, and any contraindication to vaginal birth. Use fetal monitoring before and after, consider tocolysis with terbutaline, and give anti-D immune globulin to Rh(D)-negative patients.
  • Delivery: Planned cesarean is common for persistent breech; planned vaginal breech birth is reasonable in selected cases under hospital protocols with experienced clinicians (ACOG Committee Opinion 745).
  • Transverse lie at term needs ECV or cesarean, and rupture of membranes with a transverse lie raises the risk of cord prolapse. Face, brow, and compound presentations are identified in labor; a mentum posterior face presentation cannot deliver vaginally.

Late-Term and Postterm Pregnancy

  • Definitions: Late term is 41 0/7–41 6/7 weeks; postterm is 42 0/7 weeks or later. Accurate first-trimester dating sharply reduces false postterm diagnoses.
  • Risks: Stillbirth, macrosomia and shoulder dystocia, oligohydramnios, meconium aspiration, and placental insufficiency (postmaturity syndrome).
  • Management (ACOG Practice Bulletin 146): Begin antenatal surveillance (for example, NST plus amniotic fluid assessment) at 41 0/7 weeks. Induction can be considered from 41 0/7 to 42 0/7 weeks and is recommended after 42 0/7 and by 42 6/7 weeks. Trials such as SWEPIS and INDEX found better perinatal outcomes with induction at 41 weeks, so many clinicians now induce at 41 weeks. Elective induction at 39 weeks in low-risk nulliparous patients is a reasonable option: the ARRIVE trial found it did not increase, and modestly lowered, cesarean rates.
Test Your Knowledge

A 32-year-old has a monochorionic-diamniotic twin pregnancy. At 20 weeks, ultrasound shows a deepest vertical pocket of 9 cm around twin A with a distended bladder, and 1.5 cm around twin B, whose bladder is barely visible. What is the most likely diagnosis?

A

Twin-twin transfusion syndrome

B

Normal discordance between dichorionic twins

C

Bilateral renal agenesis in twin A

D

Maternal gestational diabetes causing polyhydramnios in both sacs

Test Your Knowledge

At 34 weeks, a fetus has an estimated fetal weight at the 2nd percentile, and umbilical artery Doppler shows absent end-diastolic velocity. Amniotic fluid is normal, and the NST is reactive. According to SMFM guidance, what is the most appropriate plan?

A

Continue weekly umbilical artery Doppler surveillance and plan delivery at 39 weeks.

B

Repeat the growth ultrasound in 4 weeks before deciding on the timing of delivery.

C

Start high-dose aspirin and bed rest to improve placental blood flow and fetal growth.

D

Plan delivery at 33 0/7–34 0/7 weeks, with antenatal corticosteroids if not already given.

Test Your Knowledge

A 29-year-old G2P1, Rh(D) negative and unsensitized, has a confirmed frank breech presentation at 37 weeks. The placenta is fundal, the fetal tracing is reactive, and she has no contraindication to vaginal birth. What is the most appropriate recommendation?

A

Schedule a cesarean delivery at 37 weeks without discussing version or other options.

B

Offer external cephalic version with fetal monitoring and give anti-D immune globulin.

C

Wait for spontaneous version and schedule induction only at 42 weeks.

D

Induce labor today for a planned vaginal breech birth without further counseling.

Sections you finish are checked off in the contents.